These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26088734)

  • 1. Re: Loss-of-Function Mutations of CYP24A1, the Vitamin D 24-hydroxylase Gene, Cause Long-standing Hypercalciuric Nephrolithiasis and Nephrocalcinosis.
    Sayer JA
    Eur Urol; 2015 Jul; 68(1):164-5. PubMed ID: 26088734
    [No Abstract]   [Full Text] [Related]  

  • 2. Loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis.
    Dinour D; Beckerman P; Ganon L; Tordjman K; Eisenstein Z; Holtzman EJ
    J Urol; 2013 Aug; 190(2):552-7. PubMed ID: 23470222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,25-(OH)2D-24 Hydroxylase (CYP24A1) Deficiency as a Cause of Nephrolithiasis.
    Nesterova G; Malicdan MC; Yasuda K; Sakaki T; Vilboux T; Ciccone C; Horst R; Huang Y; Golas G; Introne W; Huizing M; Adams D; Boerkoel CF; Collins MT; Gahl WA
    Clin J Am Soc Nephrol; 2013 Apr; 8(4):649-57. PubMed ID: 23293122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel CYP24A1 genotype associated to a clinical picture of hypercalcemia, nephrolithiasis and low bone mass.
    Ferraro PM; Minucci A; Primiano A; De Paolis E; Gervasoni J; Persichilli S; Naticchia A; Capoluongo E; Gambaro G
    Urolithiasis; 2017 Jun; 45(3):291-294. PubMed ID: 27639704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AN INFANT WITH IDIOPATHIC HYPERCALCIURIA AND NEPHROLITHIASIS ASSOCIATED WITH CYP24A1 ENZYME POLYMORPHISM: A CASE REPORT.
    Trutin I; Škorić I
    Acta Clin Croat; 2022 Feb; 60(3):544-547. PubMed ID: 35282483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium and bone homeostasis in heterozygous carriers of CYP24A1 mutations: A cross-sectional study.
    Cools M; Goemaere S; Baetens D; Raes A; Desloovere A; Kaufman JM; De Schepper J; Jans I; Vanderschueren D; Billen J; De Baere E; Fiers T; Bouillon R
    Bone; 2015 Dec; 81():89-96. PubMed ID: 26117226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic causes of hypercalciuric nephrolithiasis.
    Stechman MJ; Loh NY; Thakker RV
    Pediatr Nephrol; 2009 Dec; 24(12):2321-32. PubMed ID: 18446382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy.
    Tebben PJ; Milliner DS; Horst RL; Harris PC; Singh RJ; Wu Y; Foreman JW; Chelminski PR; Kumar R
    J Clin Endocrinol Metab; 2012 Mar; 97(3):E423-7. PubMed ID: 22337913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney function and influence of sunlight exposure in patients with impaired 24-hydroxylation of vitamin D due to CYP24A1 mutations.
    Figueres ML; Linglart A; Bienaime F; Allain-Launay E; Roussey-Kessler G; Ryckewaert A; Kottler ML; Hourmant M
    Am J Kidney Dis; 2015 Jan; 65(1):122-6. PubMed ID: 25446019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A lifetime of hypercalcemia and hypercalciuria, finally explained.
    Jacobs TP; Kaufman M; Jones G; Kumar R; Schlingmann KP; Shapses S; Bilezikian JP
    J Clin Endocrinol Metab; 2014 Mar; 99(3):708-12. PubMed ID: 24423361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and biochemical phenotypes of adults with monoallelic and biallelic CYP24A1 mutations: evidence of gene dose effect.
    O'Keeffe DT; Tebben PJ; Kumar R; Singh RJ; Wu Y; Wermers RA
    Osteoporos Int; 2016 Oct; 27(10):3121-5. PubMed ID: 27129455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New Mutation of CYP24A1 in a Case of Idiopathic Infantile Hypercalcemia Diagnosed in Adulthood].
    Zanchelli F; Giudicissi A; Neri L; Sgarlato V; Bruno PF; Ruggeri M; Signorotti S; Vetrano D; Buscaroli A
    G Ital Nefrol; 2023 Dec; 40(6):. PubMed ID: 38156538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biallelic and monoallelic pathogenic variants in CYP24A1 and SLC34A1 genes cause idiopathic infantile hypercalcemia.
    Wang Q; Chen JJ; Wei LY; Ding Y; Liu M; Li WJ; Su C; Gong CX
    Orphanet J Rare Dis; 2024 Mar; 19(1):126. PubMed ID: 38504242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic Infantile Hypercalcemia, Presenting in Adulthood--No Longer Idiopathic Nor Infantile: Two Case Reports and Review.
    Tray KA; Laut J; Saidi A
    Conn Med; 2015; 79(10):593-7. PubMed ID: 26731879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluconazole in hypercalciuric patients with increased 1,25(OH)
    Bertholet-Thomas A; Portefaix A; Flammier S; Dhelens C; Subtil F; Dubourg L; Laudy V; Le Bouar M; Boussaha I; Ndiaye M; Molin A; Lemoine S; Bacchetta J
    Trials; 2022 Jun; 23(1):499. PubMed ID: 35710560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discordant Clinical Course of Vitamin-D-Hydroxylase (CYP24A1) Associated Hypercalcemia in Two Adult Brothers With Nephrocalcinosis.
    Jobst-Schwan T; Pannes A; Schlingmann KP; Eckardt KU; Beck BB; Wiesener MS
    Kidney Blood Press Res; 2015; 40(5):443-51. PubMed ID: 26304832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inherited conditions resulting in nephrolithiasis.
    Hoppe B; Martin-Higueras C
    Curr Opin Pediatr; 2020 Apr; 32(2):273-283. PubMed ID: 31789978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel homozygous W99G mutation in CLDN-16 gene causing familial hypomagnesemic hypercalciuric nephrocalcinosis in Turkish siblings.
    Alparslan C; Öncel EP; Akbay S; Alaygut D; Mutlubaş F; Tatlı M; Konrad M; Yavaşcan Ö; Kasap-Demir B
    Turk J Pediatr; 2018; 60(1):76-80. PubMed ID: 30102483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel CYP24A1 Mutation in a Young Male Patient with Nephrolithiasis: Case Report.
    Jiráčková J; Hyšpler R; Alkanderi S; Pavlíková L; Palicka V; Sayer JA
    Kidney Blood Press Res; 2019; 44(4):870-877. PubMed ID: 31288237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Monogenic Causes in Pediatric Patients with Nephrolithiasis or Nephrocalcinosis.
    Braun DA; Lawson JA; Gee HY; Halbritter J; Shril S; Tan W; Stein D; Wassner AJ; Ferguson MA; Gucev Z; Fisher B; Spaneas L; Varner J; Sayer JA; Milosevic D; Baum M; Tasic V; Hildebrandt F
    Clin J Am Soc Nephrol; 2016 Apr; 11(4):664-72. PubMed ID: 26787776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.